TSXV:ELXR

Stock Analysis Report

Executive Summary

Elixxer Ltd., an investment holding company, holds investments in private cannabis operations in Canada, Australia, Italy, Jamaica, and Switzerland.

Snowflake

Fundamentals

Limited growth with worrying balance sheet.

Share Price & News

How has Elixxer's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-7.1%

ELXR

0.5%

CA Capital Markets

0.2%

CA Market


1 Year Return

-62.9%

ELXR

14.5%

CA Capital Markets

1.2%

CA Market

Return vs Industry: ELXR underperformed the Canadian Capital Markets industry which returned 14.5% over the past year.

Return vs Market: ELXR underperformed the Canadian Market which returned 1.2% over the past year.


Shareholder returns

ELXRIndustryMarket
7 Day-7.1%0.5%0.2%
30 Day0%-1.8%-2.5%
90 Day-23.5%6.2%-1.5%
1 Year-62.9%-62.9%19.7%14.5%4.7%1.2%
3 Year-7.1%-7.1%38.9%21.9%14.0%3.8%
5 Yearn/a39.5%10.6%26.4%8.1%

Price Volatility Vs. Market

How volatile is Elixxer's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Elixxer undervalued compared to its fair value and its price relative to the market?

1.44x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate ELXR's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate ELXR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: ELXR is unprofitable, so we can't compare its PE Ratio to the Capital Markets industry average.

PE vs Market: ELXR is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate ELXR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ELXR is overvalued based on its PB Ratio (1.4x) compared to the CA Capital Markets industry average (1x).


Next Steps

Future Growth

How is Elixxer forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

108.6%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ELXR's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if ELXR's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ELXR's revenue (108.6% per year) is forecast to grow faster than the Canadian market (5.7% per year).

High Growth Revenue: ELXR's revenue (108.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if ELXR's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Elixxer performed over the past 5 years?

-43.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: ELXR is unprofitable, and losses have increased over the past 5 years at a rate of -43.3% per year.

Accelerating Growth: Unable to compare ELXR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ELXR is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (9.2%).


Return on Equity

High ROE: ELXR has a negative Return on Equity (-47.66%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: ELXR is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: ELXR is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Elixxer's financial position? (This company is analysed differently as a bank or financial institution)


Financial Position Analysis


Debt to Equity History and Analysis


Balance Sheet

Inventory Level: ELXR has a low level of unsold assets or inventory.

Debt Coverage by Assets: ELXR's debt is covered by short term assets (assets are 2.221600x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ELXR has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ELXR has less than a year of cash runway if free cash flow continues to reduce at historical rates of -33% each year


Financial Institutions Analysis

Asset Level: ELXR's level of assets compared to its equity is low.

Allowance for Bad Loans: Insufficient data to determine if ELXR has a sufficient allowance for bad loans.

Low Risk Liabilities: ELXR reports no customer deposits, loans are made up entirely of externally borrowed funds.

Loan Level: Insufficient data to determine if ELXR has an acceptable proportion of non-loan assets held.

Low Risk Deposits: ELXR has advanced significantly more loans than the customer deposits it holds.

Level of Bad Loans: Insufficient data to determine if ELXR has an appropriate level of bad loans.


Next Steps

Dividend

What is Elixxer's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%5.9%industryaverage4.4%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate ELXR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ELXR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if ELXR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELXR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ELXR's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of Elixxer's salary, the management and board of directors tenure and is there insider trading?

1.0yrs

Average management tenure


CEO

Mazen Haddad (45yo)

0.5yrs

Tenure

CA$463,943

Compensation

Mr. Mazen Haddad serves as the Chief Information Officer of Legal Research Center, Inc. Mr. Haddad served as an Interim Chief Executive Officer of Argex Titanium Inc. from December 18, 2015 to July 2016 an ...


Management Age and Tenure

1.0yrs

Average Tenure

48yo

Average Age

Experienced Management: ELXR's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Age and Tenure

4.6yrs

Average Tenure

52.5yo

Average Age

Experienced Board: ELXR's board of directors are considered experienced (4.6 years average tenure).


Insider Trading

Insider Buying: ELXR insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyCA$30,29711 Oct 19
Ferras Zalt
EntityIndividual
Role
Chairman of the Board
Chairman
Shares400,000
Max PriceCA$0.08
BuyCA$18,11623 Sep 19
Ferras Zalt
EntityIndividual
Role
Chairman of the Board
Chairman
Shares200,000
Max PriceCA$0.091
BuyCA$3,23219 Sep 19
Ferras Zalt
EntityIndividual
Role
Chairman of the Board
Chairman
Shares40,000
Max PriceCA$0.082
BuyCA$8,13029 Jul 19
John A. McMullen
EntityIndividual
Role
President
President
Shares100,000
Max PriceCA$0.085
BuyCA$19,88517 Jul 19
Ferras Zalt
EntityIndividual
Role
Chairman of the Board
Chairman
Shares200,000
Max PriceCA$0.10
BuyCA$88,03515 Jul 19
Ferras Zalt
EntityIndividual
Role
Chairman of the Board
Chairman
Shares1,000,000
Max PriceCA$0.093
BuyCA$48,00005 Jun 19
Remy Di Meglio
EntityIndividual
Role
Chief Operating Officer
Chief Operating Officer
Shares480,000
Max PriceCA$0.10
BuyCA$2,399,99404 Jun 19
Arlington Capital Partners LP
EntityCompany
Shares24,000,000
Max PriceCA$0.10
BuyCA$44,00031 May 19
Remy Di Meglio
EntityIndividual
Role
Chief Operating Officer
Chief Operating Officer
Shares440,000
Max PriceCA$0.10
BuyCA$8,000,00202 May 19
Arlington Capital Partners LP
EntityCompany
Shares80,000,000
Max PriceCA$0.10

Ownership Breakdown


Management Team

  • Guy Charette (65yo)

    Legal Council

    • Tenure: 0yrs
  • Mazen Haddad (45yo)

    CEO & Director

    • Tenure: 0.5yrs
    • Compensation: CA$463.94k
  • John A. McMullen

    President

    • Tenure: 2.7yrs
    • Compensation: CA$127.50k
  • Daniel Lubienietzky

    VP of Corporate Development

    • Tenure: 1.2yrs
  • Remy Di Meglio

    Chief Operating Officer

    • Tenure: 1yrs
  • Michael Kozub

    Corporate Secretary

    • Tenure: 1yrs
  • Kym No

    Corporate Controller

    • Tenure: 1.3yrs
  • Mark Shinners (41yo)

    Chief Financial Officer

    • Tenure: 0.5yrs
  • Richard Widmann (51yo)

    EVP of Commercial

    • Tenure: 0.5yrs
  • Jeanne van Wyk

    Vice President of Communications

    • Tenure: 0yrs

Board Members

  • Dave Lenigas (58yo)

    Director

    • Tenure: 4.6yrs
    • Compensation: CA$153.76k
  • Mazen Haddad (45yo)

    CEO & Director

    • Tenure: 0.5yrs
    • Compensation: CA$463.94k
  • Rafi Hazan (49yo)

    Director

    • Tenure: 13.8yrs
    • Compensation: CA$48.00k
  • Mohammed Ghafari

    Director

    • Tenure: 2.8yrs
    • Compensation: CA$30.00k
  • Ferras Zalt (56yo)

    Chairman

    • Tenure: 0.4yrs

Company Information

Elixxer Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elixxer Ltd.
  • Ticker: ELXR
  • Exchange: TSXV
  • Founded:
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Market Cap: CA$34.046m
  • Shares outstanding: 523.78m
  • Website: https://www.elixxer.com

Location

  • Elixxer Ltd.
  • 800 Place Victoria
  • Suite 3700
  • Montreal
  • Quebec
  • H4Z 1E9
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
QBATSXV (TSX Venture Exchange)COMCACADNo data
ELXRTSXV (TSX Venture Exchange)YesCommon SharesCACADJul 2016
ELIX.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJul 2016

Biography

Elixxer Ltd., an investment holding company, holds investments in private cannabis operations in Canada, Australia, Italy, Jamaica, and Switzerland. The company was formerly known as LGC Capital Ltd. and c ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/17 00:35
End of Day Share Price2019/10/16 00:00
Earnings2019/06/30
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.